Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling

Archives of Disease in Childhood
Rick AdmiraalCatherijne A J Knibbe

Abstract

When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups.

References

Oct 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·L B SheinerV V Marathe
Mar 1, 1997·Clinical Pharmacology and Therapeutics·L B Sheiner
Sep 19, 2003·The New England Journal of Medicine·Gregory L KearnsRalph E Kauffman
Jun 14, 2005·British Journal of Clinical Pharmacology·Trevor N Johnson
Aug 25, 2006·Clinical Pharmacokinetics·Trevor N JohnsonGeoffrey T Tucker
Oct 28, 2006·Annual Review of Pharmacology and Toxicology·Meindert DanhofRob A Voskuyl
Mar 17, 2007·Archives of Disease in Childhood·T N Johnson
Jan 25, 2008·Computer Methods and Programs in Biomedicine·Emmanuelle CometsFrance Mentré
Mar 21, 2008·Trends in Pharmacological Sciences·Meindert DanhofRob A Voskuyl
Jan 27, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Imke H BartelinkJaap Jan Boelens
Mar 24, 2009·European Journal of Clinical Pharmacology·Catherine M T SherwinDavid M Reith
Aug 5, 2009·Clinical Pharmacokinetics·Catherijne A J KnibbeDick Tibboel
Jan 28, 2010·Basic & Clinical Pharmacology & Toxicology·Leon Aarons, Kayode Ogungbenro
Mar 27, 2010·European Journal of Clinical Pharmacology·Roosmarijn F W De CockCatherijne A J Knibbe
Nov 26, 2010·European Journal of Clinical Pharmacology·Monique van DijkDick Tibboel
Dec 2, 2010·Expert Opinion on Drug Metabolism & Toxicology·Catherijne A J KnibbeMeindert Danhof
Dec 15, 2010·Pharmaceutical Research·Elke H J KrekelsCatherijne A J Knibbe
Feb 9, 2011·The AAPS Journal·Martin BergstrandMats O Karlsson
Mar 8, 2011·International Journal of Pharmaceutics·Catherijne A J Knibbe, Meindert Danhof
Jan 11, 2012·Clinical Pharmacokinetics·Roosmarijn F W De CockCatherijne A J Knibbe
Apr 5, 2012·Clinical Pharmacology and Therapeutics·E Kimland, V Odlind
Sep 14, 2012·Therapeutic Drug Monitoring·Imke H BartelinkCatherijne A J Knibbe
Nov 2, 2012·Antimicrobial Agents and Chemotherapy·Imke H BartelinkMarc Bierings
Jul 9, 2013·Archives of Disease in Childhood·Brian J Anderson, Nick H G Holford

❮ Previous
Next ❯

Citations

Aug 16, 2014·World Journal of Pediatrics : WJP·Wei ZhaoEvelyne Jacqz-Aigrain
May 8, 2015·Expert Review of Anti-infective Therapy·Eline W MuilwijkRoger J M Brüggemann
Jul 15, 2015·Expert Opinion on Drug Metabolism & Toxicology·Elke H J KrekelsCatherijne A J Knibbe
Jul 4, 2015·Clinical Pharmacokinetics·Frederique RodieuxMarc Pfister
Jan 24, 2016·Archives of Disease in Childhood·Steven Pauwels, Karel Allegaert
Sep 28, 2015·Clinical Pharmacokinetics·Miriam G MooijSaskia N de Wildt
Jan 30, 2015·Archives of Disease in Childhood·Stéphanie LerouxUNKNOWN French Society of Neonatology
Oct 5, 2014·Archives of Disease in Childhood·Mohammed I AltamimiImti Choonara
Apr 8, 2015·European Journal of Clinical Pharmacology·Mohammed I AltamimiHelen Sammons
Oct 31, 2014·Paediatric Drugs·Niina KleiberSaskia N de Wildt
Oct 24, 2014·Annual Review of Pharmacology and Toxicology·Catherijne A J KnibbeMeindert Danhof
May 2, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Meindert Danhof
May 5, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Raffaele CoppiniKarel Allegaert
Jun 9, 2016·Expert Review of Clinical Pharmacology·Janneke M BrusseeCatherijne A J Knibbe
Jul 2, 2016·The Journal of Pharmacy and Pharmacology·Anne SmitsKarel Allegaert
Jan 12, 2017·Bioinformatics·Itziar Irurzun-AranaJosé David Gómez-Mantilla
May 16, 2017·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Elke H J KrekelsCatherijne A J Knibbe
Sep 2, 2017·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·John N van den AnkerDick Tibboel
Sep 12, 2018·Journal of Clinical Pharmacology·Joshua C EuteneuerHenry T Akinbi
Dec 9, 2015·Antimicrobial Agents and Chemotherapy·Esther J H JanssenCatherijne A J Knibbe
Mar 22, 2019·Current Pharmaceutical Design·André DallmannKarel Allegaert
Aug 12, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Abraham J ValkenburgCormac V Breatnach
Dec 2, 2017·CPT: Pharmacometrics & Systems Pharmacology·Pascal SchulthessPiet H van der Graaf
Sep 2, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Monique van DijkDick Tibboel
Jan 20, 2021·Archives of Disease in Childhood·Sarah SpénardNiina Kleiber
Mar 3, 2021·Clinical and Translational Science·Fei TangMarkos Leggas
Jun 30, 2021·Journal of Clinical Pharmacology·John van den Anker, Karel Allegaert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.